Anandamide content is increased and CB1 cannabinoid receptor blockade is protective during transient, focal cerebral ischemia
- 1 January 2004
- journal article
- research article
- Published by Elsevier in Neuroscience
- Vol. 129 (3) , 743-750
- https://doi.org/10.1016/j.neuroscience.2004.08.044
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- SR141716A, a potent and selective antagonist of the brain cannabinoid receptorPublished by Wiley ,2001
- Anandamide, but not 2‐arachidonoylglycerol, accumulates during in vivo neurodegenerationJournal of Neurochemistry, 2001
- Accumulation of the anandamide precursor and other N‐acylethanolamine phospholipids in infant rat models of in vivo necrotic and apoptotic neuronal deathJournal of Neurochemistry, 2001
- Occurrence and postmortem generation of anandamide and other long‐chain N‐acylethanolamines in mammalian brainFEBS Letters, 1995
- Regional Cerebral Blood Flow after Marijuana SmokingJournal of Cerebral Blood Flow & Metabolism, 1992
- Evaluation of 2,3,5-triphenyltetrazolium chloride staining to delineate rat brain infarcts.Stroke, 1991
- Photochemical stroke model: flunarizine prevents sensorimotor deficits after neocortical infarcts in rats.Stroke, 1989
- Reversible middle cerebral artery occlusion without craniectomy in rats.Stroke, 1989
- The Stroke Data Bank: design, methods, and baseline characteristics.Stroke, 1988
- Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination.Stroke, 1986